Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3,Condition 4 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",blood insulin amount,,RS:0000784,SR,male,126 days,13,,CMO:0000342,plasma insulin level,,,,5,mU/l,0.2774,1.0,MMO:0000321,plasma insulin analysis,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days),103331,controlled sodium content diet (0.3 %) (for 42 days),controlled sodium content diet (8 %) (for 84 days),, 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",blood insulin amount,,RS:0000789,SS,male,126 days,12,,CMO:0000342,plasma insulin level,,,,6,mU/l,0.5774,2.0,MMO:0000321,plasma insulin analysis,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days),103330,controlled sodium content diet (0.3 %) (for 42 days),controlled sodium content diet (8 %) (for 84 days),, 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",blood insulin amount,,RS:0000784,SR,male,84 days,11,,CMO:0000342,plasma insulin level,,,,5,mU/l,0.603,2.0,MMO:0000321,plasma insulin analysis,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days),103329,controlled sodium content diet (0.3 %) (for 42 days),controlled sodium content diet (8 %) (for 42 days),, 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",blood insulin amount,,RS:0000789,SS,male,84 days,13,,CMO:0000342,plasma insulin level,,,,5,mU/l,0.5547,2.0,MMO:0000321,plasma insulin analysis,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days),103328,controlled sodium content diet (0.3 %) (for 42 days),controlled sodium content diet (8 %) (for 42 days),, 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",blood insulin amount,,RS:0000784,SR,male,42 days,13,,CMO:0000342,plasma insulin level,,,,4,mU/l,0.2774,1.0,MMO:0000321,plasma insulin analysis,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days),103327,controlled sodium content diet (0.3 %) (for 42 days),,, 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",blood insulin amount,,RS:0000789,SS,male,42 days,12,,CMO:0000342,plasma insulin level,,,,4,mU/l,0.5774,2.0,MMO:0000321,plasma insulin analysis,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days),103326,controlled sodium content diet (0.3 %) (for 42 days),,, 1540,"Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.",blood insulin amount,,RS:0000695,Crl:SD,male,77 days to 63 days,8,,CMO:0000342,plasma insulin level,,CT,,26,mU/l,2.0,5.6569,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled metformin content drinking water (350~500 mg/kg/d) (between 21 and 35 days),75850,controlled metformin content drinking water (350~500 mg/kg/d) (between 21 and 35 days),,, 1540,"Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.",blood insulin amount,,RS:0000695,Crl:SD,male,77 days to 63 days,10,,CMO:0000342,plasma insulin level,,FT,,32,mU/l,4.0,12.6491,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled metformin content drinking water (350~500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days),75849,controlled metformin content drinking water (350~500 mg/kg/d) (between 21 and 35 days),controlled fructose content diet (66 %) (between 14 and 28 days),, 1540,"Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.",blood insulin amount,,RS:0000695,Crl:SD,male,77 days to 63 days,8,,CMO:0000342,plasma insulin level,,C,,33,mU/l,2.0,5.6569,MMO:0000073,radioimmunoassay,,0.0,,,,,naive control condition,75848,naive control condition,,, 1540,"Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.",blood insulin amount,,RS:0000695,Crl:SD,male,77 days to 63 days,9,,CMO:0000342,plasma insulin level,,F,,51,mU/l,7.0,21.0,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled fructose content diet (66 %) (between 14 and 28 days),75847,controlled fructose content diet (66 %) (between 14 and 28 days),,, 1540,"Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.",blood insulin amount,,RS:0000695,Crl:SD,male,0 days,8,,CMO:0000342,plasma insulin level,,FT,,68,mU/l,3.0,8.4853,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled metformin content drinking water (350~500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) then insulin (2 U/kg/d) (for 14 days),75880,controlled metformin content drinking water (350~500 mg/kg/d) (between 21 and 35 days),controlled fructose content diet (66 %) (between 14 and 28 days),insulin (2 U/kg/d) (for 14 days), 1540,"Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.",blood insulin amount,,RS:0000695,Crl:SD,male,0 days,N/A,,CMO:0000342,plasma insulin level,,F,,53,mU/l,7.0,,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled fructose content diet (66 %) (between 14 and 28 days),75879,controlled fructose content diet (66 %) (between 14 and 28 days),,, 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",blood insulin amount,,RS:0000916,WKY/NHsd,male,119 days,10,,CMO:0000342,plasma insulin level,,,,64.1,mU/l,9.7,30.6741,MMO:0000164,intraperitoneal glucose tolerance test,,0,,post glucose injection,60,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,11612,fasting (for 16 hours),glucose solution (2 g/kg) ,, 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",blood insulin amount,,RS:0000363,F344/NHsd,male,119 days,10,,CMO:0000342,plasma insulin level,,,,43,mU/l,4.6,14.5465,MMO:0000164,intraperitoneal glucose tolerance test,,0,,post glucose injection,60,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,11613,fasting (for 16 hours),glucose solution (2 g/kg) ,, 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",blood insulin amount,,RS:0000916,WKY/NHsd,female,119 days,10,,CMO:0000342,plasma insulin level,,,,20,mU/l,2.5,7.9057,MMO:0000164,intraperitoneal glucose tolerance test,,0,,post glucose injection,60,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,11614,fasting (for 16 hours),glucose solution (2 g/kg) ,, 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",blood insulin amount,,RS:0000363,F344/NHsd,female,119 days,10,,CMO:0000342,plasma insulin level,,,,17,mU/l,2.4,7.5895,MMO:0000164,intraperitoneal glucose tolerance test,,0,,post glucose injection,60,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,11615,fasting (for 16 hours),glucose solution (2 g/kg) ,, 2645,"Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93.",blood insulin amount,,RS:0003219,BN-Chr 13LH/MavRrrc,male,175 days,9,,CMO:0000342,plasma insulin level,,,,23.41,mU/l,1.88,5.64,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days),102095,controlled sodium chloride content drinking water (1 %) (for 7 days),controlled sodium chloride content drinking water (2 %) (for 7 days),controlled sodium chloride content drinking water (1 %) (for 9 days),water (for 12 days) 2645,"Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93.",blood insulin amount,,RS:0002068,LH-Chr 13BN/Mav,male,175 days,10,,CMO:0000342,plasma insulin level,,,,30.84,mU/l,1.62,5.1229,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days),102094,controlled sodium chloride content drinking water (1 %) (for 7 days),controlled sodium chloride content drinking water (2 %) (for 7 days),controlled sodium chloride content drinking water (1 %) (for 9 days),water (for 12 days) 2645,"Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93.",blood insulin amount,,RS:0000556,LH/Mav,male,175 days,10,,CMO:0000342,plasma insulin level,,,,29.17,mU/l,1.42,4.4904,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days),102093,controlled sodium chloride content drinking water (1 %) (for 7 days),controlled sodium chloride content drinking water (2 %) (for 7 days),controlled sodium chloride content drinking water (1 %) (for 9 days),water (for 12 days) 2645,"Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93.",blood insulin amount,,RS:0000145,BN/NHsdMcwi,male,175 days,10,,CMO:0000342,plasma insulin level,,,,20.37,mU/l,0.91,2.8777,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days),102092,controlled sodium chloride content drinking water (1 %) (for 7 days),controlled sodium chloride content drinking water (2 %) (for 7 days),controlled sodium chloride content drinking water (1 %) (for 9 days),water (for 12 days) 3070,"Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412.",blood insulin amount,,RS:0001095,ZUC-Lepr+Ste,male,105 days to 84 days,9,,CMO:0000342,plasma insulin level,,,,26,mU/l,2.6,7.8,MMO:0000075,enzyme linked immunosorbent assay,,0.0,enzyme immunoassay (MMO:0000713),,,,fasting (for 17 hours),108658,fasting (for 17 hours),,, 3070,"Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412.",blood insulin amount,,RS:0004817,GK/CskCrlj,male,238 days to 224 days,10,,CMO:0000342,plasma insulin level,,,,28.6,mU/l,2.6,8.2219,MMO:0000075,enzyme linked immunosorbent assay,,0.0,enzyme immunoassay (MMO:0000713),,,,fasting (for 17 hours),106892,fasting (for 17 hours),,, 3070,"Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412.",blood insulin amount,,RS:0001098,ZUC-LeprfaSte-/-,male,105 days to 84 days,44,,CMO:0000342,plasma insulin level,,,,384.8,mU/l,41.6,275.9432,MMO:0000075,enzyme linked immunosorbent assay,,0.0,enzyme immunoassay (MMO:0000713),,,,fasting (for 17 hours),106938,fasting (for 17 hours),,, 3070,"Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412.",blood insulin amount,,RS:0001036,WKY/NCrlCrlj,male,238 days to 224 days,5,,CMO:0000342,plasma insulin level,,,,62.4,mU/l,10.4,23.2551,MMO:0000075,enzyme linked immunosorbent assay,,0.0,enzyme immunoassay (MMO:0000713),,,,fasting (for 17 hours),108088,fasting (for 17 hours),,, 3111,"Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z.",blood insulin amount,,RS:0001299,GK,male,77 days,10,,CMO:0000342,plasma insulin level,,plasma glucagon-like peptide 1 level (CMO:0003638),,11.7,mU/l,0.1644,0.52,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 16 hours),109085,fasting (for 16 hours),,, 3111,"Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z.",blood insulin amount,,RS:0001299,GK,male,77 days,10,,CMO:0000342,plasma insulin level,,plasma glucagon-like peptide 1 level (CMO:0003638),,11.44,mU/l,0.1644,0.52,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 16 hours),109083,fasting (for 16 hours),,, 3111,"Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z.",blood insulin amount,,RS:0001299,GK,male,77 days,10,,CMO:0000342,plasma insulin level,,plasma glucagon-like peptide 1 level (CMO:0003638),,11.96,mU/l,0.3289,1.04,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 16 hours),109082,fasting (for 16 hours),,, 2782,"Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31.",blood insulin amount,,RS:0001299,GK,female,87 days,6,,CMO:0000342,plasma insulin level,,,,23.4,mU/l,5.2,12.7373,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,bilateral ovariectomy (for 24 days),103764,bilateral ovariectomy (for 24 days),,, 2782,"Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31.",blood insulin amount,,RS:0001299,GK,female,87 days,6,,CMO:0000342,plasma insulin level,,,,26,mU/l,2.6,6.3687,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,sham surgical control condition (for 24 days),103763,sham surgical control condition (for 24 days),,, 2782,"Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31.",blood insulin amount,,RS:0001833,Crl:WI(Han),female,87 days,6,,CMO:0000342,plasma insulin level,,,,213.2,mU/l,46.8,114.6361,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,bilateral ovariectomy (for 24 days),103762,bilateral ovariectomy (for 24 days),,, 2782,"Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31.",blood insulin amount,,RS:0001833,Crl:WI(Han),female,87 days,6,,CMO:0000342,plasma insulin level,,,,221,mU/l,44.2,108.2674,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,sham surgical control condition (for 24 days),103761,sham surgical control condition (for 24 days),,, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",blood insulin amount,,RS:0001216,COP.DA-(D3Rat233-D3Mgh14)/Mco,not specified,105 days,10,,CMO:0000342,plasma insulin level,,,,26.52,mU/l,8.06,25.488,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 16 hours),68574,fasting (for 16 hours),,, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",blood insulin amount,,RS:0001215,COP.DA-(D16Rat12-D16Rat90)/Mco,not specified,105 days,10,,CMO:0000342,plasma insulin level,,,,32.5,mU/l,7.54,23.8436,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 16 hours),68573,fasting (for 16 hours),,, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",blood insulin amount,,RS:0000186,COP/OlaHsd,not specified,105 days,10,,CMO:0000342,plasma insulin level,,,,29.12,mU/l,5.72,18.0882,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 16 hours),68572,fasting (for 16 hours),,, 1037,"Klimes I, et al., Diabetologia 2003 Mar;46(3):352-8.",blood insulin amount,,RS:0000148,BN/OrlIcoCrlf,not specified,120 days,10,,CMO:0000342,plasma insulin level,,,,14.04,mU/l,1.9733,6.24,MMO:0000321,plasma insulin analysis,,0.0,,,,,fasting (for 16 hours),68985,fasting (for 16 hours),,, 1037,"Klimes I, et al., Diabetologia 2003 Mar;46(3):352-8.",blood insulin amount,,RS:0000397,HTG,not specified,120 days,10,,CMO:0000342,plasma insulin level,,,,13,mU/l,2.7132,8.58,MMO:0000321,plasma insulin analysis,,0.0,,,,,fasting (for 16 hours),68984,fasting (for 16 hours),,, 1012,"Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29.",blood insulin amount,,RS:0002495,GK/Ox,female,60 days,6,,CMO:0000342,plasma insulin level,,,,9.1,mU/l,1.378,3.3754,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (between 16 and 18 hours),68779,fasting (between 16 and 18 hours),,, 1012,"Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29.",blood insulin amount,,RS:0002495,GK/Ox,male,60 days,6,,CMO:0000342,plasma insulin level,,,,18.798,mU/l,2.392,5.8592,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (between 16 and 18 hours),68778,fasting (between 16 and 18 hours),,, 1012,"Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29.",blood insulin amount,,RS:0000134,BN/Crl,female,60 days,6,,CMO:0000342,plasma insulin level,,,,6.058,mU/l,0.806,1.9743,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (between 16 and 18 hours),68777,fasting (between 16 and 18 hours),,, 1012,"Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29.",blood insulin amount,,RS:0000134,BN/Crl,male,60 days,6,,CMO:0000342,plasma insulin level,,,,6.396,mU/l,1.118,2.7385,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (between 16 and 18 hours),68776,fasting (between 16 and 18 hours),,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",blood insulin amount,,RS:0000117,BN.GK-(D8Got302-D8Got130)/Ox,male,168 days,10,,CMO:0000342,plasma insulin level,,,,5.323745,mU/l,0.7194,2.275,MMO:0000326,intravenous glucose tolerance test,,0.0,plasma insulin analysis,,,,naive control condition,67338,naive control condition,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",blood insulin amount,,RS:0000119,BN.GK-(D8Rat29-D8Got130)/Ox,female,168 days,7,,CMO:0000342,plasma insulin level,,,,4.31655,mU/l,0.8633,2.2841,MMO:0000326,intravenous glucose tolerance test,,0.0,plasma insulin analysis,,,,naive control condition,67337,naive control condition,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",blood insulin amount,,RS:0000134,BN/Crl,female,168 days,10,,CMO:0000342,plasma insulin level,,,,7.050365,mU/l,1.4389,4.55,MMO:0000326,intravenous glucose tolerance test,,0.0,plasma insulin analysis,,,,naive control condition,67336,naive control condition,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",blood insulin amount,,RS:0000117,BN.GK-(D8Got302-D8Got130)/Ox,female,84 days,18,,CMO:0000342,plasma insulin level,,,,2.733815,mU/l,0.4317,1.8314,MMO:0000326,intravenous glucose tolerance test,,0.0,plasma insulin analysis,,,,naive control condition,67335,naive control condition,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",blood insulin amount,,RS:0000119,BN.GK-(D8Rat29-D8Got130)/Ox,female,84 days,10,,CMO:0000342,plasma insulin level,,,,6.04317,mU/l,1.0072,3.185,MMO:0000326,intravenous glucose tolerance test,,0.0,plasma insulin analysis,,,,naive control condition,67334,naive control condition,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",blood insulin amount,,RS:0000134,BN/Crl,female,84 days,12,,CMO:0000342,plasma insulin level,,,,4.31655,mU/l,0.4317,1.4953,MMO:0000326,intravenous glucose tolerance test,,0.0,plasma insulin analysis,,,,naive control condition,67333,naive control condition,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",blood insulin amount,,RS:0000117,BN.GK-(D8Got302-D8Got130)/Ox,male,168 days,11,,CMO:0000342,plasma insulin level,,,,3.309355,mU/l,0.4317,1.4316,MMO:0000326,intravenous glucose tolerance test,,0.0,plasma insulin analysis,,,,naive control condition,67332,naive control condition,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",blood insulin amount,,RS:0000119,BN.GK-(D8Rat29-D8Got130)/Ox,male,168 days,12,,CMO:0000342,plasma insulin level,,,,6.762595,mU/l,1.295,4.4859,MMO:0000326,intravenous glucose tolerance test,,0.0,plasma insulin analysis,,,,naive control condition,67331,naive control condition,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",blood insulin amount,,RS:0000134,BN/Crl,male,168 days,20,,CMO:0000342,plasma insulin level,,,,5.46763,mU/l,0.7194,3.2174,MMO:0000326,intravenous glucose tolerance test,,0.0,plasma insulin analysis,,,,naive control condition,67330,naive control condition,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",blood insulin amount,,RS:0000117,BN.GK-(D8Got302-D8Got130)/Ox,male,84 days,15,,CMO:0000342,plasma insulin level,,,,3.45324,mU/l,0.7194,2.7863,MMO:0000326,intravenous glucose tolerance test,,0.0,plasma insulin analysis,,,,naive control condition,67329,naive control condition,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",blood insulin amount,,RS:0000119,BN.GK-(D8Rat29-D8Got130)/Ox,male,84 days,12,,CMO:0000342,plasma insulin level,,,,4.02878,mU/l,0.7194,2.4922,MMO:0000326,intravenous glucose tolerance test,,0.0,plasma insulin analysis,,,,naive control condition,67328,naive control condition,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",blood insulin amount,,RS:0000134,BN/Crl,male,84 days,15,,CMO:0000342,plasma insulin level,,,,7.19425,mU/l,1.0072,3.9008,MMO:0000326,intravenous glucose tolerance test,,0.0,plasma insulin analysis,,,,naive control condition,67327,naive control condition,,,